Literature DB >> 27759187

Proportion of Patients With Hypertension Resolution Following Adrenalectomy for Primary Aldosteronism: A Systematic Review and Meta-Analysis.

Jamie L Benham1, Maysoon Eldoma1, Bushra Khokhar2, Derek J Roberts3, Doreen M Rabi4, Gregory A Kline1.   

Abstract

Unilateral primary aldosteronism (PA) is often treated with adrenalectomy, but hypertension resolution rates are variable. A valid estimate of the postoperative normotension rate is necessary to inform the utility of PA testing and treatment. The authors searched MEDLINE In-Process & Other Non-Indexed Citations, Embase, and Cochrane Central Register of Controlled Trials. Prospective adult cohort studies with surgically treated PA that reported resolution of hypertension without the aid of medications were included. Among 2620 abstracts identified by the search, 25 studies in the systematic review with data on 1685 patients were investigated. The pooled proportion of normotension following adrenalectomy was 52% (95% confidence interval, 0.44-0.60). Meta-regression demonstrated a significant negative association between length of follow-up and proportion of normotension, with normotension dropping by 6.7% per year of follow-up (coefficient -0.006; 95% confidence interval, -0.01 to 0.002). Overall, approximately half of the patients experienced hypertension resolution, although this outcome may not be durable in all patients. ©2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27759187      PMCID: PMC8031514          DOI: 10.1111/jch.12916

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  48 in total

Review 1.  Primary aldosteronism: cardiovascular, renal and metabolic implications.

Authors:  Gian-Paolo Rossi; Leonardo A Sechi; Gilberta Giacchetti; Vanessa Ronconi; Pasquale Strazzullo; John W Funder
Journal:  Trends Endocrinol Metab       Date:  2008-03-07       Impact factor: 12.015

2.  Retroperitoneoscopic adrenalectomy in Conn's syndrome caused by adrenal adenomas or nodular hyperplasia.

Authors:  Martin K Walz; Roland Gwosdz; Stephanie L Levin; Piero F Alesina; Anna-Carinna Suttorp; Klaus A Metz; Frank A Wenger; Stephan Petersenn; Klaus Mann; Kurt W Schmid
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

Review 3.  Genetic and potential autoimmune triggers of primary aldosteronism.

Authors:  Tracy Ann Williams; Paolo Mulatero; Martin Bidlingmaier; Felix Beuschlein; Martin Reincke
Journal:  Hypertension       Date:  2015-06-08       Impact factor: 10.190

4.  Primary aldosteronism: functional histopathology and long-term follow-up after unilateral adrenalectomy.

Authors:  Cristina Volpe; Bertil Hamberger; Anders Höög; Kuniaki Mukai; Jan Calissendorff; Hans Wahrenberg; Jan Zedenius; Marja Thorén
Journal:  Clin Endocrinol (Oxf)       Date:  2014-12-19       Impact factor: 3.478

Review 5.  [Primay hyperaldosteronism--diagnostic and treatment].

Authors:  S A Potthoff; F Beuschlein; O Vonend
Journal:  Dtsch Med Wochenschr       Date:  2012-11-20       Impact factor: 0.628

6.  Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.

Authors:  Masao Omura; Jun Saito; Kunio Yamaguchi; Yukio Kakuta; Tetsuo Nishikawa
Journal:  Hypertens Res       Date:  2004-03       Impact factor: 3.872

7.  Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production.

Authors:  J C Rutherford; W L Taylor; M Stowasser; R D Gordon
Journal:  World J Surg       Date:  1998-12       Impact factor: 3.352

8.  Characteristics predicting clinical improvement and cure following laparoscopic adrenalectomy for primary aldosteronism in a large cohort.

Authors:  Patrick J Worth; Nicholas R Kunio; Issac Siegfried; Brett C Sheppard; Erin W Gilbert
Journal:  Am J Surg       Date:  2015-08-17       Impact factor: 2.565

9.  Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism.

Authors:  J Hennings; S Andreasson; J Botling; A Hägg; A Sundin; P Hellman
Journal:  Langenbecks Arch Surg       Date:  2009-05-06       Impact factor: 3.445

Review 10.  Proportion of Patients With Hypertension Resolution Following Adrenalectomy for Primary Aldosteronism: A Systematic Review and Meta-Analysis.

Authors:  Jamie L Benham; Maysoon Eldoma; Bushra Khokhar; Derek J Roberts; Doreen M Rabi; Gregory A Kline
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-19       Impact factor: 3.738

View more
  9 in total

Review 1.  Primary aldosteronism: a common cause of resistant hypertension.

Authors:  Gregory A Kline; Ally P H Prebtani; Alexander A Leung; Ernesto L Schiffrin
Journal:  CMAJ       Date:  2017-06-05       Impact factor: 8.262

2.  Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism.

Authors:  Wessel M C M Vorselaars; Sjoerd Nell; Emily L Postma; Rasa Zarnegar; F Thurston Drake; Quan-Yang Duh; Stephanie D Talutis; David B McAneny; Catherine McManus; James A Lee; Scott B Grant; Raymon H Grogan; Minerva A Romero Arenas; Nancy D Perrier; Benjamin J Peipert; Michael N Mongelli; Tanya Castelino; Elliot J Mitmaker; David N Parente; Jesse D Pasternak; Anton F Engelsman; Mark Sywak; Gerardo D'Amato; Marco Raffaelli; Valerie Schuermans; Nicole D Bouvy; Hasan H Eker; H Jaap Bonjer; N M Vaarzon Morel; Els J M Nieveen van Dijkum; Otis M Vrielink; Schelto Kruijff; Wilko Spiering; Inne H M Borel Rinkes; Gerlof D Valk; Menno R Vriens
Journal:  JAMA Surg       Date:  2019-04-17       Impact factor: 14.766

Review 3.  Proportion of Patients With Hypertension Resolution Following Adrenalectomy for Primary Aldosteronism: A Systematic Review and Meta-Analysis.

Authors:  Jamie L Benham; Maysoon Eldoma; Bushra Khokhar; Derek J Roberts; Doreen M Rabi; Gregory A Kline
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-19       Impact factor: 3.738

4.  Some Considerations About Primary Aldosteronism and Its Follow-Up.

Authors:  Decio Armanini; Chiara Sabbadin; Alessandra Andrisani; Guido Ambrosini; Luciana Bordin
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-19       Impact factor: 3.738

5.  Predicting factors related with uncured hypertension after retroperitoneal laparoscopic adrenalectomy for unilateral primary aldosteronism.

Authors:  WuYun BiLiGe; Chaoqi Wang; JiRiGaLa Bao; Dahai Yu; A Min; Zhi Hong; Xiangbao Chen; Min Wang; Dongmei Wang
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

6.  Predictors of Clinical Success After Surgery for Primary Aldosteronism in the Japanese Nationwide Cohort.

Authors:  Mitsuha Morisaki; Isao Kurihara; Hiroshi Itoh; Mitsuhide Naruse; Yoshiyu Takeda; Takuyuki Katabami; Takamasa Ichijo; Norio Wada; Takanobu Yoshimoto; Yoshihiro Ogawa; Masakatsu Sone; Mika Tsuiki; Hirotaka Shibata; Junji Kawashima; Megumi Fujita; Minemori Watanabe; Yuichi Matsuda; Hiroki Kobayashi; Tomoko Suzuki
Journal:  J Endocr Soc       Date:  2019-08-22

7.  Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: An efficacy and safety, proof-of-principle trial.

Authors:  Hexuan Zhang; Qiang Li; Xiaoli Liu; Zhigang Zhao; Hongbo He; Fang Sun; Yangning Hong; Xunmei Zhou; Yingsha Li; Rufei Shen; Xiaona Bu; Zhencheng Yan; Hongting Zheng; Gangyi Yang; Zhiming Zhu
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-27       Impact factor: 3.738

Review 8.  Hypertension outcomes of adrenalectomy in patients with primary aldosteronism: a systematic review and meta-analysis.

Authors:  Yu Zhou; Meilian Zhang; Sujie Ke; Libin Liu
Journal:  BMC Endocr Disord       Date:  2017-10-03       Impact factor: 2.763

9.  Thirty-six-month results of laparoscopic-based renal denervation plus unilateral laparoscopic adrenalectomy for the treatment of patients with resistant hypertension caused by unilateral aldosterone-producing adenoma.

Authors:  Yahui Liu; Binbin Zhu; Lijie Zhu; Linwei Zhao; Zhiqiang Fan; Degang Ding; Zhonghua Liu; Qiuping Zhao; Datun Qi; You Zhang; Ji-Guang Wang; Chuanyu Gao
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-16       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.